Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
Evaluate the IOP-lowering efficacy and quality of life in patients using bimatoprost 0.03% monotherapy versus dual therapy with travoprost 0.004% and timolol 0.5% for the treatment of glaucoma or ocular hypertension.
Epistemonikos ID: f7538b878926110aa6cd5ce6ba58ac48bde5d7c5
First added on: May 04, 2024